Home > PJ (current issue) > News / News Centre | Search

PJ Online homeThe Pharmaceutical Journal
Vol 276 No 7406 p743
24 June 2006

This article
Reprint   Photocopy

  Acrobat Reader


News summary

Related websites
“Infection control guidance for care homes” PDF (440K)


Infection control guidance published for care homes

BSIP, LECA/Science Photo Library

Care homes

It is important that prescribers indicate duration of any antimicrobial treatment

Guidance from the Department of Health on controlling health care-associated infection in care homes has been published this week.

Sarah Garner, pharmacist, Specialist Advisory Committee on Antimicrobial Resistance, was involved with the medicines management section of the document, which includes information on managing antibiotic selection and resistance, drug administration, adverse events and storage of medicines. She told The Journal that the specific advice on antimicrobials complements the Royal Pharmaceutical Society’s “Guidance on the administration and control of medicines in care homes and children’s services”, which is being updated this year.

“Pharmacists can provide support and information to care homes to enable them to manage their antimicrobial use appropriately and prevent resistance,” said Dr Garner.

“In particular, pharmacists can work with care homes to ensure that the prescriber has supplied adequate details of the dose, frequency of administration and, importantly, the duration of treatment,” she added.

The document also contains information about hand hygiene, waste (including the disposal of pharmaceutical products), immunisation and safe handling and disposal of sharps.

NHS delivery programme The DoH has issued “The delivery programme to reduce healthcare associated infections (HCAI) including MRSA” designed to support NHS hospital trusts.

Back to Top


©The Pharmaceutical Journal